Enbrel 50 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DR26FGJ1B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,559
Award facts
- Contract value 100% obligated
- $11,558.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,558.70 to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injectors on October 28, 2025, with completion scheduled for October 29, 2025. This firm fixed-price delivery order represents a non-competitive award utilizing the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. The performance location for this delivery order is the company's corporate office in Conshohocken, Pennsylvania.
This delivery order supplies ENBREL (etanercept), a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions, demonstrating AmerisourceBergen Drug Corp's role in providing specialty medications to the Defense Health Agency and other federal healthcare programs. As a child delivery order under the larger SPE2DX prime IDC, this award reflects the ongoing pharmaceutical supply chain operations supporting DoD medical requirements. The company's comprehensive federal contract portfolio encompasses a wide range of therapeutic domains including specialty medications, biologics, vaccines, and medical devices, positioning it as a key supplier for military healthcare logistics across global operations.
Quick answers
Who was awarded contract SPE2DR26FGJ1B?
SPE2DR26FGJ1B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DR26FGJ1B worth?
The government has obligated $11,559 on SPE2DR26FGJ1B.
Is contract SPE2DR26FGJ1B an order under another contract?
Yes. SPE2DR26FGJ1B is a delivery order under SPE2DR25D1002, an indefinite delivery contract.
Was contract SPE2DR26FGJ1B competed?
The extent of competition for SPE2DR26FGJ1B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award